Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A minimalist illustration of a tumor and a drug capsule in flat design.

Oct 23, 2026

Multiomic Study of MSS CRC Identifies Vulnerabilities Pointing to Therapeutic Possibilities

An international research initiative has unveiled potential therapeutic avenues for microsatellite stable (MSS) colorectal cancer (CRC), a subtype known for its treatment resistance. Spearheaded by RCSI University of Medicine and Health Sciences and The Institute of Cancer Research, London, the study integrated extensive multiomic data from approximately 2,000 CRC tumors, utilizing an AI tool named iPhenMap to create detailed biological tumor maps.The findings revealed specific vulnerabilities w
Press release cover image

Oct 23, 2026

Press release

TraceLink Launches Track & Trace Lakehouse to Expand Compliance and Analytical Access to End-to-End Serialized Events

Built on the OPUS Lakehouse, the new capability gives life sciences and healthcare customers SQL-based access to serialized event data, with integrated reporting and analytics through OPUS Reports and DashboardsBOSTON, Oct. 23, 2026 /PRNewswire/ -- TraceLink, the world's largest Agentic Business Network, today announced the launch of Track & Trace Lakehouse, a new capability that gives life sciences and healthcare companies analytical access to end-to-end serialized product events. Built on
A cozy armchair with a cup of tea in a dimly lit living room

Oct 23, 2026

Telemental health roundup: Talkiatry expands nationwide

The expansion of telehealth services is reshaping access to mental health care across the United States, with significant developments from Talkiatry and local initiatives in New York City.Talkiatry has announced its nationwide expansion, providing psychiatric and therapy services across all 50 states. This move addresses the challenges faced by patients who experience disruptions in care due to multistate licensure issues. The company emphasizes the importance of coordinated care, enabling pati
Press release cover image

Oct 23, 2026

Press release

Medical Care Technologies Inc. (OTCID:MDCE) Engages Task-Based Software Technicians and External Platforms to Accelerate Technology and Enterprise Expansion

Company Adds Specialized Technical Capacity to Speed Development Across AI Platforms, Software Offerings, and Consulting Services MESA, AZ / ACCESS Newswire / October 23, 2026 / Medical Care Technologies Inc. (OTCID:MDCE) today announced that it is working with task-based software technicians and other software platforms to support the expansion and acceleration of its technology, platforms, and enterprise services. The engagements are structured around discrete technical workstreams, including
A robotic surgical arm in an operating room with surgical instruments.

Oct 23, 2026

Nelson Advisors: This Week in European HealthTech, MedTech and Health AI: 23rd October 2026

This week in European HealthTech saw significant developments, including a major investment in surgical robotics, advancements in AI certification, and notable funding rounds across the sector.Stryker announced a strategic partnership with CMR Surgical, committing around $400 million to gain exclusive sales rights for the Versius robotic surgery system in the U.S. This investment not only secures a pivotal role in the surgical robotics market but also allows CMR to maintain its development effor
Press release cover image

Oct 23, 2026

Press release

Coreline Soft Receives U.S. FDA 510(k) Clearance for AVIEW Aorta Metrics, Expanding Its Chest CT AI Portfolio in the U.S.

Secures its 13th FDA 510(k) clearance, expanding its U.S. portfolio from lung nodule detection and coronary artery calcium (CAC) analysis to quantitative aortic assessmentEnables automated aortic segmentation and diameter measurements across anatomical regions, broadening the quantitative capabilities of chest CTWill showcase the AVIEW platform and its U.S. clinical implementation strategy at RSNA 2026 in NovemberSEOUL, South Korea and CHICAGO, Oct. 23, 2026 /PRNewswire/ -- Coreline Soft has rec
A minimalist representation of a brain symbolizing AI in healthcare.

Oct 23, 2026

HIMSSCast: What should be required to validate health AI models?

In a recent discussion, Dr. Katherine Eisenberg, a physician informaticist and senior medical director for Dyna AI at EBSCO, examined the critical aspects of validating health AI models, especially in light of OpenEvidence's Darwin model achieving a perfect score on MedQA.Dr. Eisenberg has been at the forefront of evaluating AI's effectiveness in clinical settings, contributing her expertise to initiatives like the Coalition for Health AI and the Digital Medicine Society's AI Governance project.
Press release cover image

Oct 23, 2026

Press release

Galderma’s Relfydess™ (relabotulinumtoxinA) Receives Approval in China for Frown Lines

The Chinese National Medical Products Administration (NMPA) has approved Relfydess™, the first and only ready-to-use liquid neuromodulator designed with PEARL™ Technology, for the temporary improvement of moderate-to-severe glabellar lines (frown lines) in adults1,2The approval is based on phase III results from a local clinical trial conducted in China as well as global READY clinical trials, with local results reinforcing that Relfydess delivers significant improvements in frown lines, with a
Press release cover image

Oct 23, 2026

Press release

Marengo Therapeutics Announces Landmark Nature Medicine Publication Establishing First-in-Human Proof of Vβ-Directed T-Cell Biology and Antitumor Activity

First-in-human results from the STARt-001 Phase 1/2 clinical trial demonstrate selective activation of Vβ6/Vβ10 T cells expands functional effector and memory populations, generating single-agent antitumor activity in heavily pretreated, checkpoint-resistant solid tumorsPeer-reviewed findings establish the human biological foundation for invikafusp alfa and validate Marengo's STAR, TriSTAR and MSTAR precision immunotherapy platformsCAMBRIDGE, Mass., Oct. 23, 2026 /PRNewswire/ -- Marengo Therapeu
Press release cover image

Oct 23, 2026

Press release

BioLineRx and Hemispherian Present Preclinical Data Demonstrating Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancer at ESMO 2026

GLIX1 demonstrated reproducible synergy across different PARP inhibitors and multiple HR-proficient ovarian cancer cell lines, with high ZIP synergy scores, highlighting GLIX1's potential to expand the efficacy of PARP inhibitorsIn an HR-proficient ovarian cancer patient-derived xenograft model, low-doses of GLIX1 plus olaparib demonstrated statistically significant tumor growth inhibition versus vehicle control, and tumor growth inhibition comparable to cisplatinTEL AVIV, Israel, and OSLO, Norw
Press release cover image

Oct 23, 2026

Press release

Alebund Pharmaceuticals Announces Poster Presentation by Partner R1 Therapeutics of Global Phase IIb Multi-Regional Clinical Trial Design for AP306 at ASN Kidney Week 2026

SHANGHAI, Oct. 23, 2026 /PRNewswire/ -- Alebund Pharmaceuticals (Jiangsu) Limited ("Alebund" or the "Company"; HKEX: 09637), a renal-focused biopharmaceutical company, today announced that its partner, R1 Therapeutics, Inc. ("R1"), presented a trial-in-progress poster outlining the design of the ongoing global Phase IIb multi-regional clinical trial of AP306, a first-in-class oral pan-phosphate transporter inhibitor, in patients with hyperphosphatemia receiving maintenance hemodialysis (NCT06712
A glass vial with a drug compound in a laboratory setting.

Oct 23, 2026

US Treasury proposes curbs on Chinese biotech deals

The US Treasury's recent proposal to limit investments in Chinese biotech could significantly impact future drug development collaborations.China has become a pivotal source for drug candidates, but the US Treasury's new measures aim to restrict licensing agreements with Chinese firms. This initiative is part of an update to the Outbound Investment Security Programme (OISP), which seeks to limit US investments in advanced technologies in nations deemed "countries of concern," including China, Ru